Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor

Circulation Journal - Japan
doi 10.1253/circj.cj-11-1102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Transition From Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Ii-Receptor-Blocker to Sacubitril/Valsartan in Chronic Heart Failure Patients: Initial Experiences in Clinical Practice

Cor et Vasa
Cardiovascular MedicineCardiology
2018English

The Significance of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Use in Sudden Cardiac Death

International Journal of Clinical Medicine
2017English

Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Cardioprotective Effects of Benazepril, an Angiotensin-Converting Enzyme Inhibitor, in an Ischaemia-Reperfusion Model of Myocardial Infarction in Rats

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2009English

Angiotensin Converting Enzyme Gene Deletion Allele Is Independently and Strongly Associated With Coronary Atherosclerosis and Myocardial Infarction.

Heart
Cardiovascular MedicineCardiology
1995English

Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors

Hypertension
Internal Medicine
2004English

Acute Effects of Angiotensin-Converting Enzyme Inhibitor on the Failing Heart.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1994English

Aspirin and Angiotensin-Converting Enzyme Inhibitors Among Elderly Survivors of Hospitalization for an Acute Myocardial Infarction

Archives of Internal Medicine
2001English

Effects of Acute Angiotensin II Type 1 Receptor Antagonism and Angiotensin Converting Enzyme Inhibition on Plasma Fibrinolytic Parameters in Patients With Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy